151 related articles for article (PubMed ID: 36812381)
1. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract][Full Text] [Related]
2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
[TBL] [Abstract][Full Text] [Related]
4. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
[TBL] [Abstract][Full Text] [Related]
5. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
[TBL] [Abstract][Full Text] [Related]
6. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
Johnson C; Parsa L; Gibbs J; Sligh J
J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
8. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
[TBL] [Abstract][Full Text] [Related]
9. EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.
Michal M; Berry RS; Rubin BP; Kilpatrick SE; Agaimy A; Kazakov DV; Steiner P; Ptakova N; Martinek P; Hadravsky L; Michalova K; Szep Z; Michal M
Am J Surg Pathol; 2018 Oct; 42(10):1325-1333. PubMed ID: 29957732
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
[TBL] [Abstract][Full Text] [Related]
11. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
12. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
Shaker N; Abu Shakra R; Sangueza OP
Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
[TBL] [Abstract][Full Text] [Related]
13. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
Bruce-Brand C; Conradie W; Schneider JW
Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
[TBL] [Abstract][Full Text] [Related]
14. Superficial CD34-Positive Fibroblastic Tumor.
Perret R; Hostein I
Surg Pathol Clin; 2024 Mar; 17(1):1-12. PubMed ID: 38278599
[TBL] [Abstract][Full Text] [Related]
15. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
Li SY; Zhang HL; Bai YZ
Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
[TBL] [Abstract][Full Text] [Related]
16. PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.
Lacambra MD; Weinreb I; Demicco EG; Chow C; Sung YS; Swanson D; To KF; Wong KC; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2019 Oct; 58(10):705-712. PubMed ID: 31008539
[TBL] [Abstract][Full Text] [Related]
17. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
[TBL] [Abstract][Full Text] [Related]
19. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy.
Carter JM; Weiss SW; Linos K; DiCaudo DJ; Folpe AL
Mod Pathol; 2014 Feb; 27(2):294-302. PubMed ID: 23887307
[TBL] [Abstract][Full Text] [Related]
20. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
